AstraZeneca
As an Associate Director of Digital Proteomics and AI Innovation at AstraZeneca, you will bridge mass spectrometry-based proteomics with agentic AI to build intelligent systems for cancer vaccine research. This role involves designing and deploying AI-enabled workflows that integrate multi-omic data to drive biological insights and scientific discovery. You will collaborate closely with informaticians and domain scientists to establish data standards and scalable analytical environments.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
23% above the average for this role
AI Biologist - Proteomics
DOOR
Huck Institutes of the Life Sciences NSF NCEMS Postdoctoral Scholar-Computational Proteomics/Mass Spectrometry
pennstate.edu
Proteomics Scientist
Proxima
Research Associate II, Proteomics
Revolution Medicines
Future Talent Program Co-op - Early Discovery Neuroscience
MSD
Principal Scientist, Mass Spectrometry
Moderna